Phase I/II study of the combination of arsenic trioxide with ascorbic acid and high-dose melphalan for patients with multiple myeloma.
Phase of Trial: Phase I/II
Latest Information Update: 28 Jul 2014
At a glance
- Drugs Arsenic trioxide (Primary) ; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 13 May 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History